Table 2.
Governance domains, gaps, and proposed actions for addressing AI-related inequalities in health systems
| Domain | Current gaps | Proposed action | Cost of inaction |
|---|---|---|---|
| Legal frameworks | Fragmented governance; restrictive licensing; limited LMIC data-sharing | Align with FAIR principles; embed equity in EHDS-type frameworks; benefit-sharing agreements | Data poverty persists; AI underperforms for underserved populations |
| Evidence generation | Poor demographic reporting; N-of-1 LLM evaluations; no equity endpoints | Mandate subgroup reporting; repeated-sampling designs; a priori acceptability thresholds | Technologies approved on evidence blind to at-risk populations |
| Regulation & market access | No AI-specific representativeness standards; volume-based payment | Minimum representativeness for market access; equity incentives; value-based payment | Benefits concentrated in commercially attractive populations |
| Workforce | Inconsistent AI curricula; unequal training access; deskilling risk | Systematic competency integration; equitable resourcing; atrophy safeguards | Two-tier care quality by provider training access |
| Public trust | Limited citizen voice; transparency deficits; environmental concerns | Democratic oversight; environmental impact in evaluation; community engagement | AI lacks social licence; reforms lack legitimacy |